sodium nitroprusside
- Product NDC
- 14789-012
- 11-digit product format
- 147890012
- Labeler code
- 14789
- Product ID
- 14789-012_f3a91a00-5e2f-4bcb-a11f-9458cced50c7
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- sodium nitroprusside
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Labeler
- Nexus Pharmaceuticals Inc
- Application
- ANDA207499
- Marketing category
- ANDA
- Marketing start
- 2017-05-29
- Marketing end
- 0000-00-00
- Substance
- SODIUM NITROPRUSSIDE
- Active strength
- 25 mg/mL
- Pharmacologic classes
- Vasodilation [PE], Vasodilator [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 14789-012 | SODIUM NITROPRUSSIDE INJECTION [NEXUS PHARMACEUTICALS LLC] | 9 | Legacy NDC | 20241211_870b8428-3e48-40f5-9172-d962adc90dd5.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 14789-012-02 | 14789001202 | 1 VIAL, GLASS in 1 CARTON (14789-012-02) > 2 mL in 1 VIAL, GLASS | 2017-05-29 | 0000-00-00 | No | No | Current |